Supply of Sumatriptan Succinate Injection (Pharmaceutical Product)

The contract entails the supply and delivery of 1,000 units of Sumatriptan Succinate Injection, an FDA-approved injectable medication used to treat migraines, adhering strictly to current Good Manufacturing Practices and Department of Defense packaging standards to ensure safety, efficacy, and compliance with military requirements. The product is classified under NAICS code 325412, indicating its designation within pharmaceutical manufacturing, and is being procured under a subcontract arrangement through the Defense Logistics Agency, representing the Department of Defense. Although specific delivery locations and point of contact details are not provided, the transaction is linked to a DLA award record, suggesting this is part of a broader logistics effort to maintain medical readiness and supply chain integrity for military and government health systems. The solicitation was posted in July 2026, indicating this is a future-oriented acquisition aligned with anticipated operational needs.